OVERVIEW

The Latest Guidelines and Antiviral Therapies for Influenza: What You Need to Know for 2019-2020 is organized by Prime Education LLC.

Dates:
Release Date: December 4, 2019
Expiration Date: December 3, 2020

Accreditation:
• 1.0 CME/CE for Physicians (ACCME)
• 1.0 CME/CE for Physician Assistants (AAPA)
• 1.0 CME/CE for Nurse Practitioners (AANP)
• 1.0 CPE for Pharmacists (ACPE + NABP)
• 1.0 CNE for Nurses (ANCC)
• 1.0 CE for Case Managers (CCM, pre-approved)

Activity Overview:
According to the CDC, the 2018–2019 influenza season was the longest in 10 years. The flu vaccine was only 29% effective this season, due to a strain of H3N2 that emerged in the spring. These trends illustrate the unpredictability of this virus and the need for timely and effective treatments. Listen in as leading experts share the latest interprofessional strategies for preventing influenza, identifying infected patients (including those at high risk for complications), and initiating treatment.

You won't want to miss:
• The latest advances in antiviral treatment
• The most recent guidelines for influenza management and other factors influencing therapy selection
• Approaches for providers, payers, pharmacists, and patients to improve the timely administration of influenza antivirals in order to alleviate the burden of this disease

Learning Objectives:
• Identify current gaps in the prevention and treatment of influenza A and B
• Differentiate approved and emerging antiviral therapies for influenza A and B based on their efficacy and safety, as well as dosage and administration profiles, to guide individualized treatment decision-making
• Apply current and emerging data to educate the interprofessional team of payers and providers about new antiviral treatment for influenza, detection of symptoms, and prompt initiation of treatment